Your browser does not support iframes.
Michael (Mike) McClellan was appointed Executive Vice President, Chief Financial Officer in November, 2017 and will oversee the Finance Group, Business Development, Investor Relations and Information Technology. He has served as Teva Interim Group CFO since July 2017. previusly, he had served as SVP & CFO Global Specialty Medicines since July 2015. Prior to joining Teva, Mike was the U.S. CFO at Sanofi, where his career spanned nearly 20 years in roles of increased responsibility in global finance and healthcare. Mr. McClellan received his BSBA, Accounting & Economics from the University of Missouri Trulaske College of Business.